Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 5/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482317 | 1.00 | HCAR2 (0.55) | HCAR2ACHEBACE1FAAHATM | |
| SCHEMBL11407409 | 1.00 | HCAR2 (0.55) | HCAR2ACHEBACE1FAAHATM | |
| SCHEMBL9150192 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL11747182 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL11747171 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL9153654 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL11750529 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL9149032 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL9153650 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 | |
| SCHEMBL9149024 | 0.93 | HCAR2 (0.56) | HCAR2FAAHCNR1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3006494-B1 | RESIN COMPOSITION, OPTICAL COMPENSATION FILM EMPLOYING SAME, AND PRODUCTION METHOD FOR SAME | TOSOH CORP (JP) | 2019-07-31 | — | — | EP | disclosed |
| EP-3208301-B1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORP (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-10126478-B2 | Resin composition and optical compensation film using same | TOSOH CORPORATION (JP) | 2018-11-13 | — | — | US | disclosed |
| US-9932488-B2 | Resin composition, optical compensation film using same, and production method for same | TOSOH CORPORATION (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20170242174-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORPORATION (JP) | 2017-08-24 | — | — | US | disclosed |
| EP-3208301-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | Tosoh Corporation (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-20160115333-A1 | RESIN COMPOSITION, OPTICAL COMPENSATION FILM USING SAME, AND PRODUCTION METHOD FOR SAME | TOSOH CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
| EP-3006494-A1 | RESIN COMPOSITION, OPTICAL COMPENSATION FILM EMPLOYING SAME, AND PRODUCTION METHOD FOR SAME | Tosoh Corporation (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-8420764-B2 | Compound having silsesquioxane skeleton and its polymer | JNC CORPORATION (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20120178894-A1 | COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER | INAGAKI JYUN-ICHI (JP) | 2012-07-12 | — | — | US | disclosed |
| US-7705105-B2 | A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; | CHISSO PETROCHEMICAL CORPORATION (JP) | 2010-04-27 | — | — | US | disclosed |
| US-20070190344-A1 | Verification of translation | JNC CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | CHISSO CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-4199619-A | REACTION ON BASE SHEET BETWEEN COLOR FORMER IN FORM OF MICROENCAPSULATED OILY CORE MATERIAL AND ORGANIC ACCEPTOR COATED WITH CAROBXYLIC LATEX ON BASE SHEET | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1980-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | C1S, H1-4, H1-0 | HCAR2 2928/4885ACHE 3372/4885BACE1 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.